Verinurad
CAS: 1352792-74-5
Ref. 3D-CEC79274
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued | ||
100mg | Discontinued |
Product Information
Verinurad is a small-molecule drug that inhibits the activity of the chemokine receptor CXCR4. Verinurad has been shown to be effective in reducing HIV viral load in patients with metabolic disorders. The pharmacodynamics of verinurad is characterized by its inhibition of CXCR4 binding and receptor activity, which leads to reduced chemokine production. Verinurad also has a high affinity for the CXCR4 receptor and this property leads to a rapid process optimization and increased efficacy of the drug.